Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

COGT stock hub

Cogent Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

COGTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

COGT

In the news

Latest news · COGT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-85.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-41.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All COGT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001622229
Company name	Cogent Biosciences, Inc.
Country	United States
Country code	US
Cusip	19240Q201
Employees	258
Employees Change	53%
Employees Change Percent	25.85
Enterprise value	$5.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-03-29
Isin	US19240Q2012
Last refreshed	2026-05-10
Market cap	$5.9B
Market cap category	Mid-Cap
Price	$34.74
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	COGT
Website	https://www.cogentbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.97%
FCF yield	-4.82%
P/B ratio	10.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-354.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-38.13
Roa5y	-36.66
ROCE	-42.84
ROE	-85.72
Roe5y	-68.01
ROIC	-41.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	637.02%
Cagr3y	45.74%
Cagr5y	33.13%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$903M
Cash	$866.4M
Current Assets	$877.8M
Current Liabilities	$58M
Debt	$238.7M
Debt Equity	$0.39
Equity	$607.7M
Interest Coverage	-84.69
Liabilities	$295.3M
Long Term Assets	$25.2M
Long Term Liabilities	$237.3M
Net Cash	$627.7M
Net Cash By Market Cap	$10.57
Net Cash Growth	174.63%
Net Debt Equity	$-1.03
Tangible Book Value	$542.9M
Tangible Book Value Per Share	$3.18
WACC	6.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.14
Net Working Capital	$-45.2M
Quick ratio	14.94
Working Capital	$819.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.75%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	636.02%
200-day SMA	28.09
3Y total return	209.63%
50-day SMA	36.22
50-day SMA vs 200-day SMA	50over200
5Y total return	318.05%
All Time High	43.73
All Time High Change	-20.56%
All Time High Date	2025-12-08
All Time Low	3.67
All Time Low Change	846.59%
All Time Low Date	2023-12-11
ATR	1.45
Beta	0.37
Beta1y	-0.15
Beta2y	0.93
Ch YTD	-2.2
High	35.4
High52	43.73
High52 Date	2025-12-08
High52ch	-20.56%
Low	34.47
Low52	4.55
Low52 Date	2025-05-19
Low52ch	663.52%
Ma50ch	-4.09%
Premarket Change Percent	2.21
Premarket Price	$35.56
Premarket Volume	408
Price vs 200-day SMA	23.67%
RSI	39.95
RSI Monthly	69.99
RSI Weekly	54.89
Sharpe ratio	1.92x
Sortino ratio	8.66
Total Return	-6.75%
Tr YTD	-2.2
Tr1m	-2.47%
Tr1w	-5.16%
Tr3m	-6.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	9
Analyst Price Target Top	$37
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.54
Operating Income	$-362M
Price target	$36.43
Price Target Change	$4.87
Price Target Change Top	$6.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	160,859,776%
Float Percent	94.12%
Net Borrowing	217,756,000
Shares Insiders	0.56%
Shares Institutions	101.47%
Shares Out	170,911,934
Shares Qo Q	8.12%
Shares Yo Y	6.75%
Short Float	7.48%
Short Ratio	4.69
Short Shares	7.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-339.3M
Average Volume	1,664,603.6x
Bv Per Share	3.18
CAPEX	$-1.5M
Ch1m	-2.47
Ch1w	-5.16
Ch1y	636
Ch3m	-6.31
Ch3y	209.6
Ch5y	318.1
Ch6m	134.4
Change	-0.14%
Change From Open	-0.57
Close	34.79
Days Gap	0.43
Depreciation Amortization	2,550,000
Dollar Volume	31,130,409.8
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-362M
EBITDA	$-359.5M
EPS	$-2.51
F Score	2
FCF	$-286.3M
FCF EV Yield	-5.39x
FCF Per Share	$-1.67
Financing CF	905,799,000
Fiscal Year End	December
Founded	2,014
Investing CF	-505,362,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2020-11-09
Last Split Type	Reverse
Last10k Filing Date	2026-02-17
Ma150	33.34
Ma150ch	4.2%
Ma20	36.31
Ma20ch	-4.32%
Net CF	115,621,000
Next Earnings Date	2026-08-04
Open	34.94
Optionable	Yes
Position In Range	29.03
Ppne	22,847,000
Pre Close	34.79
Price Date	2026-05-08
Ptbv Ratio	10.94
Relative Volume	0.54x
Share Based Comp	52,979,000
Tr6m	134.41%
Us State	Massachusetts
Volume	896,097

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does COGT pay a dividend?

Capital-return profile for this ticker.

Performance

COGT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns COGT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+101.5%

Float: +94.1% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

COGT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.0

Neutral momentum band

Price vs 200-day MA

+23.7%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

1.92

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About COGT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current COGT stock rating?

Cogent Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full COGT analysis?

The full report lives at /stocks/COGT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for COGT?

The latest report frames COGT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the COGT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.